1.A Study on the Conduction Veloctiy of the Median and Ulnar Nerves in Healthy Korean
Moon Sik HAHN ; Jin Kwan CHANG
The Journal of the Korean Orthopaedic Association 1982;17(4):575-587
It is obvious that the examination of nerve conduction as a diagnostic tool is a relatively new field of interest with a state of still undergoing evaluation and improvement. Problems of technique and interpretation notwithstanding, determination of nerve conduction has progressed to a level where it is now used routinely as a part of the electrodiagnostic examination. The present study has been undertaken to determine the normal range of the motor nerve conduction velocity, distal motor latency, amplitude of the muscle action potentials, sensory nerve conduction velocity, distal sensory latency, amplitude and duration of the sensory nerve action potentials of median and ulnar nerves in healthy Korean. One hundred twenty healthy subjects (sixty male and sixty female) were examined. Their ages ranged from 5 to 69 in years and the subjects were arranged in three age groups of 5–9 years, 10–49 years and 50–69 years. The results obtained were as follows: l. In median nerve, mean values for motor nerve conduction velocity, distal motor latency, and amplitude of the muscle action potantials were 56.57± 4.55 (45.2–69.4) m/sec, 3.02±0.48 (1.6–4.5) msec, and 14.2±5.0 (4–28) mV, respectively. 2. In ulnar nerve, mean values for motor nerve conduction velocity, distal motor latency, and amplitude of the muscle action potentials were 58.60±5.06 (43.5–71.4) m/sec, 2.35±0.50 (1.3–4.1) msec, and 11.7±3.7(4–22) mV, respectively. 3. In median nerve, mean values for sensory nerve conduction velocity, distal sensory latency, amplitude and duration of the sensory nerve action potentials were 63.50±5.63 (53.1–75.9) m/sec, 2.37±0.38 (1.0–3.4) msec, 45.5±16.9 (13–120)u V, and 1.68±0.29 (0.9–2.5) msec, respectively. 4. In ulner nerve, mean values for sensory nerve conduction velocity, distal sensory latency, amplitude and duration of the sensory nerve action potentials were 65.34±5.16 (50.6–78.1) m/sec, 2.09±0.38 (1.3–3.2) msec, 45.6±17.5 (12–118) uV, and 1.54±0.32 (0.8–2.5) msec, respectively. In comparison of the obtained values of two nerves. 5. A significant difference was observed between motor nerve conduction studies of the median and ulnar nerves. 6. A significant difference was observed between sensory nerve conduction studies of the median and ulnar nerves except amplitude of the sensory nerve action potentials. 7. Nerve conduction velocity was significantly faster in sensory nerve than in motor nerve. In comparison of conduction velocities among 3 age groups. 8. Motor nerve conduction velocity of the median and ulnar nerves was slow in age groups of 5–9 years and 50–69 years as compared with that of age group of 10–49 years. 9. Sensory nerve conduction velocity of median nerve was slow in age groups of 5–9 years and 50–69 years as compared with that of age group of 10–49 years, and sensory nerve conduction velocity of ulnar nerve was slow in age group of 50–69 years as compared with that of age groups of 5–9 years and 10–49 years.
Action Potentials
;
Healthy Volunteers
;
Humans
;
Male
;
Median Nerve
;
Neural Conduction
;
Reference Values
;
Ulnar Nerve
2.Lymphangiomatosis.
Ki Soo KIM ; Kwan Sik LEE ; Tae Soo CHANG
Journal of the Korean Surgical Society 1991;41(5):695-699
No abstract available.
3.Lymphangiomatosis.
Ki Soo KIM ; Kwan Sik LEE ; Tae Soo CHANG
Journal of the Korean Surgical Society 1991;41(5):695-699
No abstract available.
4.A STUDY OF SCOLIOSIS Part I. Surgical Treatment
Se Il SUK ; Yung Sik YANG ; Jin Kwan CHANG
The Journal of the Korean Orthopaedic Association 1976;11(3):339-352
No abstract available in English.
Scoliosis
5.A Case of Urachal Actinomycosis.
Chang Kyung CHOI ; Hee Kwan RIM ; Hong Sung KIM ; Joung Sik RIM
Korean Journal of Urology 2000;41(1):183-186
No abstract available.
Actinomycosis*
6.A Case of Urachal Actinomycosis.
Chang Kyung CHOI ; Hee Kwan RIM ; Hong Sung KIM ; Joung Sik RIM
Korean Journal of Urology 2000;41(1):183-186
No abstract available.
Actinomycosis*
7.Staghorn Calculi in Renal Allograft Treated with Percutaneous Nephrolithotripsy through Graft Renal Pelvis.
Korean Journal of Urology 2004;45(1):91-92
The formation of urinary calculi following renal transplantation is rare event with a frequency of less than 5%. Although infection, renal tubular acidosis and cyclosporine-induced hyperuricosuria can predispose toward stone formation in a renal allograft. The modalities of treatment used, were percutaneous nephrolithotripsy, shock wave lithotripsy and chemolysis. We report a case in which a double-J ureteral stent that had been forgotten for 10 years induced staghorn calculi in allograft. The stone was successfully removed by percutaneous ultrasonic nephrolithotripsy through graft renal pelvis.
Acidosis, Renal Tubular
;
Allografts*
;
Calculi*
;
Kidney Calculi
;
Kidney Pelvis*
;
Kidney Transplantation
;
Lithotripsy
;
Shock
;
Stents
;
Transplants*
;
Ultrasonics
;
Ureter
;
Urinary Calculi
8.Spontaneous Regression of Residual Arteriovenous Malformation.
Tae Sik CHANG ; Sung Nam HWANG ; Kwan PARK ; Duck Young CHOI
Journal of Korean Neurosurgical Society 1993;22(8):925-928
After removal of a large arteriovenous malformation which was fed by middle cerebral artery and posterior cerebral artery and drained toward superior sagittal sinus, transverse sinus in the left parieto-occipital area, post-operative angiography showed a small residual arteriovenous malformation. The patient was recommended follow-up angiography instead of immediated operation. Angiography was performed one year later and it showed no residual arteriovenous malformation which was thought to be occluded spontaneously.
Angiography
;
Arteriovenous Malformations*
;
Follow-Up Studies
;
Humans
;
Middle Cerebral Artery
;
Posterior Cerebral Artery
;
Superior Sagittal Sinus
9.Stomach Cancer Arising from Remmnant Stomach 14 Years after Gastrectomy of EGC Type I (m).
U Chang CHOI ; Kyung Hee KIM ; Kwan Sik LEE ; Young Myoung MOON ; Hy De LEE ; Hyeon Joo JEONG
Korean Journal of Gastrointestinal Endoscopy 1989;9(1):25-27
Recently therapeutic efficacy of stomach cancer was greatly improved due to early diagnosis and irnproved diagnostic and therapeutic modalities. Especially in early gastric cancer, 5 year survival rate is near 100%. Recarrence of early gastric cancer after curative surgery is rarely reported. Recently authors experienced one case of recurrent stomach cancer arising from remmnant stomach 14 years after gastrectomy of EGC type I(m), so we reports it here with review of literatures.
Early Diagnosis
;
Gastrectomy*
;
Stomach Neoplasms*
;
Stomach*
;
Survival Rate
10.Comparative Analysis between Sextant Biopsy and 12-samples Needle Biopsy for Detection of Stage T1c Prostate Cancer.
Korean Journal of Urology 2004;45(7):653-657
PURPOSE: The incidence of stage T1c prostate cancer has been reported to have increased more than any other prostate cancer. To evaluate whether a sextant biopsy is useful for the detection of stage T1c prostate cancer, the detection rates were compared between the sextant and 12-sample needle biopsies, in relation to the prostate volume (PV) and serum prostate specific antigen (PSA) level. MATERIALS AND METHODS: Between January, 1986 and December, 2002, 123 patients who were found to be normal upon digital rectal examination, with negative findings on a transrectal ultra sonography (TRUS) examination and elevated serum PSA (>4ng/ml), underwent either a sextant or 12-sample needle biopsy, under local anesthesia, to detect the presence of prostate cancer. RESULTS: There was no statistically significant difference in the cancer detection rate between the sextant (11/41) and 12-sample (24/82) needle biopsies of the prostate. According to the total PSA level, the detection rates of prostate cancer for the 6 and 12 core groups were 31.6 (6/19) and 22.8% (8/35), respectively, (PSA: 4.1-9.9ng/ml), 23.1 (3/13) and 32.0% (8/25) (PSA: 10.0-19.9ng/ml), and 22.2 (2/9) and 36.4% (8/22) (PSA >or=20.0ng/ml). According to the prostate volume, the detection rates of prostate cancer for the 6 and 12 core groups were 28.6 (2/7) and 31.0% (9/29), respectively (PV
Anesthesia, Local
;
Biopsy*
;
Biopsy, Needle*
;
Digital Rectal Examination
;
Humans
;
Incidence
;
Needles*
;
Prostate*
;
Prostate-Specific Antigen
;
Prostatic Neoplasms*